ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism

Overview of attention for article published in Genome Biology, January 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 76 publications that cite this research output.

76

The most recent citing publications are shown below. View all 76 publications that cite this research output on Dimensions.

RNA modification‐related EIF4G2 is an immunotherapy determinant in osteosarcoma: A single‐cell sequencing analysis

Article in Environmental Toxicology (April 2024)

Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1/Nrf2 pathway

Article in Experimental Hematology & Oncology (March 2024)

Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma

Article in Cells (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.